National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 67645 [2024-18712]

Download as PDF Federal Register / Vol. 89, No. 162 / Wednesday, August 21, 2024 / Notices 71. Sharon Delcorro, Murrells Inlet, South Carolina, Court of Federal Claims No: 24– 1133V 72. Drake Gaines, Bradenton, Florida, Court of Federal Claims No: 24–1134V 73. Cynthia Bell-Bonds, Spokane, Washington, Court of Federal Claims No: 24–1137V 74. Arielle Lewis, Los Angeles, California, Court of Federal Claims No: 24–1138V 75. Alvin Thomas, III, Orlando, Florida, Court of Federal Claims No: 24–1139V 76. Nancy Wasserstein, Brooklyn, New York, Court of Federal Claims No: 24–1142V 77. Christy Williams, Conyers, Georgia, Court of Federal Claims No: 24–1143V 78. Ronald Cato, Spartanburg, South Carolina, Court of Federal Claims No: 24– 1145V 79. Angel Acevedo, Sioux Falls, South Dakota, Court of Federal Claims No: 24– 1146V 80. Tracy Ray, New York, New York, Court of Federal Claims No: 24–1149V 81. Zachary Haller, Pittsburgh, California, Court of Federal Claims No: 24–1153V 82. Edward Quiroz, Surprise, Arizona, Court of Federal Claims No: 24–1156V 83. Teresa Betancourt, West New York, New Jersey, Court of Federal Claims No: 24– 1157V 84. Kathleen A. Merante, Pittsburgh, Pennsylvania, Court of Federal Claims No: 24–1158V 85. Katrina Nazreth, Columbia, South Carolina, Court of Federal Claims No: 24– 1162V 86. Ameleah Pfeiffer, Warren, Michigan, Court of Federal Claims No: 24–1163V 87. Joseph Virissimo on behalf of M.V., Las Vegas, Nevada, Court of Federal Claims No: 24–1168V 88. James McMahon, Dresher, Pennsylvania, Court of Federal Claims No: 24–1169V 89. Michael Gross, Minneapolis, Minnesota, Court of Federal Claims No: 24–1170V 90. James Wilkerson, Spooner, Wisconsin, Court of Federal Claims No: 24–1172V 91. James McDowell, Silver Spring, Maryland, Court of Federal Claims No: 24– 1173V 92. Eric Ruffo, San Antonio, Texas, Court of Federal Claims No: 24–1174V [FR Doc. 2024–18733 Filed 8–20–24; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health lotter on DSK11XQN23PROD with NOTICES1 National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose VerDate Sep<11>2014 17:17 Aug 20, 2024 Jkt 262001 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; R25 Review—Short Courses, Mentoring Networks, and Education Programs for Psychiatry Residents. Date: September 25, 2024. Time: 11:00 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual meeting). Contact Person: EMMA Perez-Costas, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, 6001 Executive Blvd., Rockville, MD 20852, (240) 936–6720, emma.perez-costas@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: August 15, 2024. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18682 Filed 8–20–24; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). Date: September 20, 2024. Time: 10:00 a.m. to 12:30 p.m. Frm 00059 Fmt 4703 Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F21B, Rockville, MD 20852 (Video Assisted). Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F21B, Rockville, MD 20852, 240–669–5026, haririmf@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 15, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18712 Filed 8–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Fiscal Year (FY) 2024 Notice of Supplemental Funding Opportunity Substance Abuse and Mental Health Services Administration, Department of Health and Human Services (HHS). ACTION: Notice of intent to award supplemental funding. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 67645 Sfmt 4703 This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting administrative supplements in scope of the parent award for the 12 eligible grant recipients funded in FY 2022 under the Tribal Behavioral Health Grant Program (Short Title: Native Connections), Notice of Funding Opportunity (NOFO) SM–21– 011. Recipients may receive up to $77,500 each for a total of $930,000 across the grant cohort. These recipients have a project end date for these supplemental funds of September 29, 2025. The supplemental funding will be used to fund a comprehensive Training of Trainers (ToT) model to enhance and expand workforce development and capacity in the areas of focus of the TBH program: preventing and reducing substance use, overdose, suicidal behavior, suicide, and addressing the impact of trauma among American Indian/Alaska Native (AI/AN) youth, up to and including age 24. FOR FURTHER INFORMATION CONTACT: Shannon Hastings, NOFO Lead, SUMMARY: E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 89, Number 162 (Wednesday, August 21, 2024)]
[Notices]
[Page 67645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18712]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator Initiated 
Program Project Applications (P01 Clinical Trial Not Allowed).
    Date: September 20, 2024.
    Time: 10:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F21B, 
Rockville, MD 20852 (Video Assisted).
    Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F21B, 
Rockville, MD 20852, 240-669-5026, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 15, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-18712 Filed 8-20-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.